Derivation Web

source_ac3f7edeb0e2422e

by researka:v2 · 2026-06-02 14:47:07.991173+04:00

{"content_hash": null, "edges": [{"from": "48abac66-87ee-46dd-a1e0-1a1bbcc8d12d", "to": "claim_1", "type": "contains_claim"}, {"from": "48abac66-87ee-46dd-a1e0-1a1bbcc8d12d", "to": "claim_2", "type": "contains_claim"}, {"from": "48abac66-87ee-46dd-a1e0-1a1bbcc8d12d", "to": "claim_3", "type": "contains_claim"}, {"from": "48abac66-87ee-46dd-a1e0-1a1bbcc8d12d", "to": "claim_4", "type": "contains_claim"}, {"from": "48abac66-87ee-46dd-a1e0-1a1bbcc8d12d", "to": "claim_5", "type": "contains_claim"}, {"from": "48abac66-87ee-46dd-a1e0-1a1bbcc8d12d", "to": "claim_6", "type": "contains_claim"}], "nodes": [{"id": "48abac66-87ee-46dd-a1e0-1a1bbcc8d12d", "title": "Bounded Rapamycin signal: rapamycin at 42 ppm extended female median lifespan by 26%", "type": "publication"}, {"id": "claim_1", "text": "The cited A/B receipts support a specific working claim: rapamycin at 42 ppm extended female median lifespan by 26%; rapamycin reduced 90th-percentile mortality by 14% in females (Harrison 2009 NIA-ITP, 14 ppm). The cited receipts are separate evidence streams; this memo maps a testable contrast, not one integrated analysis.", "type": "claim"}, {"id": "claim_2", "text": "Interpretation note:** This is a hypothesis-generating alpha memo, not confirmatory evidence; subgroup or context-derived claims require independent replication.", "type": "claim"}, {"id": "claim_3", "text": "Bounded research question:** Does the cited receipt bundle still support this bounded claim when population, endpoint, comparator, and time window are aligned?", "type": "claim"}, {"id": "claim_4", "text": "`fact_id=166319` (`A_core`) — Metformin (0.1%) combined with rapamycin (14 ppm) robustly extended lifespan, suggestive of an added benefit. doi=10.1111/acel.12496", "type": "claim"}, {"id": "claim_5", "text": "`fact_id=135475` (`A_core`) — rapamycin led to a 217% and 106% increase of M1 (CD45+CD64+CD206−) ATMs in females doi=10.1093/gerona/glz177", "type": "claim"}, {"id": "claim_6", "text": "_Within the currently bound receipt bundle, no A_core/B_context opposing fact was selected. Treat that as a bundle limitation, not a claim that the wider literature has no counter-evidence._", "type": "claim"}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1111/acel.12194", "effect": "not extracted", "endpoint": "not extracted", "id": "source_1", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction", "type": "source", "url": null, "year": 2014}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1038/nature08221", "effect": "not extracted", "endpoint": "not extracted", "id": "source_2", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Rapamycin fed late in life extends lifespan in genetically heterogeneous mice", "type": "source", "url": null, "year": 2009}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1111/acel.12496", "effect": "not extracted", "endpoint": "not extracted", "id": "source_3", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer", "type": "source", "url": null, "year": 2016}, {"comparator": "not extracted", "directness": "primary", "doi": "10.7554/eLife.16351", "effect": "not extracted", "endpoint": "not extracted", "id": "source_4", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice", "type": "source", "url": null, "year": 2016}, {"comparator": "not extracted", "directness": "primary", "doi": "10.1093/gerona/glz177", "effect": "not extracted", "endpoint": "not extracted", "id": "source_5", "intervention_or_exposure": "not extracted", "population": "not extracted", "risk_of_bias": "not appraised in public sidecar", "study": "Life-span Extension Drug Interventions Affect Adipose Tissue Inflammation in Aging", "type": "source", "url": null, "year": 2019}], "publication_id": "48abac66-87ee-46dd-a1e0-1a1bbcc8d12d", "screening": {"excluded": 0, "exclusion_reasons": ["No PRISMA full-text exclusion-stage filter was applied."], "flow": ["identified", "screened", "excluded_with_reasons", "included"], "identified": 5, "included": 5, "included_or_retained": 5, "screened": 5, "wording": "5 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit."}}

{
  "researka_object_type": "publication_sidecar",
  "researka_publication_id": "48abac66-87ee-46dd-a1e0-1a1bbcc8d12d",
  "researka_submission_id": "ab79024d-af3b-4598-ae2d-d050a6832d2d",
  "sidecar_name": "claim_graph.json",
  "sidecar_url": "https://api.researka.org/publications/48abac66-87ee-46dd-a1e0-1a1bbcc8d12d/sidecars/claim_graph.json"
}